AstraZeneca buys vaccine startup; FDA issues GLP-1 safety warning
BioPharma Dive · 11h ago
AstraZeneca
Medicine & Biotech · covered by 22 outlets this week · tracked since 2026-10-27
Press: 6 mainstream 23 specialist 6 independent outlet-days
Background
AstraZeneca plc (AZ) is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. Wikipedia ↗
Written by the Alivewire editors from the coverage below, 19h ago. Not medical advice; how the ratings work.
Coverage
AstraZeneca Acquires Omniose to Strengthen Vaccine Development Against Serious Bacterial Infections
Medical Dialogues · 15h ago
AstraZeneca snaps up vaccine technology company
Life Science Sweden · 16h ago
eltranslation pending
Εποχική γρίπη: Η AstraZeneca ενημερώνει τους γονείς για τον αντιγριπικό εμβολιασμό των παιδιών
Medlabnews · 1d ago
FDA approves neoadjuvant/adjuvant durvalumab for resectable non-small cell lung cancer
FDA Drug Safety / Drugs feed · 1d ago
FDA approves osimertinib for locally advanced, unresectable (stage III) non-small cell lung cancer following chemoradiation therapy
FDA Drug Safety / Drugs feed · 1d ago
eltranslation pending
Αυτό Δεν το Πρόλαβες! Την εποχική γρίπη όμως, θα μπορούσες να την προλάβεις!
Iatronet · 1d ago
EFN: Could AstraZeneca make a move for Sobi?
Life Science Sweden · 2d ago
opinion
The AstraZeneca Foundation Awards Over $1.1 Million to Expand Community Healthcare Access
OncoDaily · 4d ago
FDA approves durvalumab for limited-stage small cell lung cancer
FDA Drug Safety / Drugs feed · 5d ago
FDA approves acalabrutinib with bendamustine and rituximab for previously untreated mantle cell lymphoma
FDA Drug Safety / Drugs feed · 5d ago
FDA approves durvalumab with chemotherapy for mismatch repair deficient primary advanced or recurrent endometrial cancer
FDA Drug Safety / Drugs feed · 5d ago
FDA approves capivasertib with abiraterone and prednisone for PTEN-deficient androgen pathway modulation-naïve or -sensitive prostate cancer
FDA Drug Safety / Drugs feed · 5d ago
AstraZeneca Makes USD 10 Billion Bid for Obesity Drugmaker Rhythm Pharmaceuticals
Medical Dialogues · 5d ago
study
Daiichi Sankyo and AstraZeneca Enter into Clinical Trial Collaboration with Summit …
Longevity.Technology · 6d ago
sv
AstraZeneca also bets big on obesity drugsÄven Astra Zeneca satsar stort på obesitasläkemedel
Läkemedelsvärlden · 6d ago
Sources: AstraZeneca bid $10 billion for Rhythm Pharmaceuticals
Life Science Sweden · 6d ago
Democrats get their health agenda ready ahead of takeover
The Hill Healthcare · 7d ago
estranslation pending
Una IA para detectar tumores hepáticos da el salto al entorno hospitalario en Barcelona
Redacción Médica · 7d ago
Why Cancer Biomarker Testing Is Personal for Mark-Paul Gosselaar
Healthline · 9d ago
Earnings roundup: AstraZeneca’s cost cuts, Alnylam’s slump and Regeneron’s resilience
BioPharma Dive · 9d ago
Regulatory filings for lung cancer therapy advance
PharmaTimes · 9d ago
AstraZeneca drops two early-stage prostate cancer drugs
Life Science Sweden · 9d ago
study
BioNTech, DualityBio say ADC had ‘modest’ benefit in breast cancer study
BioPharma Dive · 16d ago
AstraZeneca Readies New Portfolio of Targeted Cancer Therapies
WSJ Health · 17d ago
China’s rapid human trials draw western drugmakers — and safety concerns
Financial Times Health · 19d ago
AstraZeneca India opens new Mumbai office for next phase of growth through innovation
BioSpectrum India · 25d ago
AstraZeneca, FDC, Nutricia lead corporate growth as pharma market strengthens in September 2026
BioSpectrum India · 27d ago
Pharma brands gain momentum in September 2026 as Electral, Brilinta lead value-volume growth
BioSpectrum India · 27d ago
Cambridge and AstraZeneca extend programme to support PhD students
University of Cambridge News · 28d ago
NIPER Raebareli and AstraZeneca India partner to strengthen clinical research capabilities
BioSpectrum India · 28d ago
A Case of Misdirected Immunity
Virology Blog · 216d ago